Publication: NFKB and NFKBI polymorphisms in
relation to susceptibility of tumour and other diseases
Loading...
Date
2007
Authors
Sun, X-F. ; Zhang, H.
item.page.secondaryauthor
item.page.director
Publisher
Murcia: F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Nuclear factor-kB (NF-kB) is responsible for
the expression by regulating many genes for immune
response, cell adhesion, differentiation, proliferation,
angiogenesis and apoptosis. The function of NF-kB is
inhibited by binding to NF-kB inhibitor (IkB), and
imbalance of NF-kB and IkB has been associated with
development of many diseases, including tumours. In
this review, we focus on polymorphisms of the NFKB
and NFKBI genes in relation to development of common
inflammatory diseases including ulcerative colitis (UC),
Crohn’s disease (CD), rheumatoid arthritis, systemic
lupus erythematosus, psoriatic arthritis, giant cell
arthritis, type 1 diabetes, multiple sclerosis, celiac
disease, and Parkinson’s disease, as well as susceptibility
of several cancers, such as oral squamous cell
carcinoma, colorectal cancer (CRC), hepatocellular
carcinoma, breast cancer and myeloma.
publication.page.subject
Citation
item.page.embargo
Ir a Estadísticas
Sin licencia Creative Commons.